FDA-approved sleeping pill offers new hope in the fight against Alzheimer's disease
Alzheimer’s disease is notorious for robbing individuals of memory and cognitive function. Researchers have struggled for ...
MedPage Today17 小时
Alzheimer's Lecanemab Treatment Up to 36 Months Supported by Extension Study
SAN DIEGO -- Biomarker and cognitive data supported treatment with the anti-amyloid agent lecanemab (Leqembi) for up to 36 ...